CALGARY,
AB, May 1, 2023 /CNW/ - Nanalysis Scientific
Corp. ("Nanalysis" or the "Company", TSXV: NSCI,
OTCQX: NSCIF, FRA: 1N1) is pleased to announce that due to strong
investor demand, the Company has increased the size of its
previously announced non-brokered private placement of units of the
Company (the "Units"). The Company will now issue up to
6,881,167 Units at a price of $0.60
per Unit for aggregate gross proceeds of up to $4,128,700 (the "Offering").
Other than the increase in the size of the Offering, all other
terms and conditions of the Offering remain unchanged, as described
in the press release dated April 21,
2023.
The completion of the Offering will be subject to acceptance of
the Offering by the TSX Venture Exchange. It is anticipated that
the second closing of the Offering will occur on or about
May 2, 2023, subject to satisfaction
of all closing conditions. The Units, including all underlying
securities thereof, will have a hold period of four months and one
day from the date of issue.
About Nanalysis Scientific Corp.
(TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1)
Nanalysis' business is what we term "MRI and NMR for industry".
The Company develops and manufactures portable Nuclear Magnetic
Resonance (NMR) spectrometers or analyzers for laboratory and
industrial markets. The NMReady-60™ was the first full-feature
portable NMR spectrometer in a single compact enclosure requiring
no liquid helium or any other cryogens. The company has followed-up
that initial offering with new products and continues to have a
strong innovation pipeline. In 2020 Nanalysis announced the launch
of its100MHz device, the most powerful and most advanced compact
NMR device ever brought to market.
Nanalysis' devices are used in many industries (oil and gas,
chemical, mining, pharma, biotech, flavor and fragrances,
agrochemicals, law enforcement, and more) as well as numerous
government and university research labs around the world. The
Company continues to exploit new global market opportunities
independently and with partners.
In 2022 the Company acquired K'(Prime) Technologies Inc.
(KPrime), a North American sales and service company of over 40
individuals who cover scientific instrumentation for pharma, food,
chemical and oil & gas customers, as well as imaging systems
for security applications.
Additionally in 2022, the Company acquired a 43% ownership in
Quad Systems AG ("Quad Systems"), a Zurich-based Nuclear
Magnetic Resonance (NMR) company focused on high-field NMR for
pharmaceutical and other vertical markets.
Notice regarding Forward Looking
Statements and Legal Disclaimer
This news release contains certain "forward-looking
statements" within the meaning of such statements under applicable
securities law relating to regulatory approval for the Offering and
statements relating to the successful closing of the second tranche
of the Offering and anticipated timing thereof and other matters
ancillary or incidental to the foregoing.
All statements included herein, other than statements of
historical fact, may be forward-looking information and such
information involves various risks and uncertainties.
Forward-looking information is often, but not always, identified by
the use of words such as "anticipates", "plan", "continue",
"expect", "project", "intend", "believe", "anticipate", "estimate",
"may", "will", "potential", "proposed", "positioned" and other
similar words, or statements that certain events or conditions
"may" or "will" occur. These statements are only predictions.
Various assumptions were used in drawing the conclusions or making
the projections contained in the forward-looking statements
throughout this news release. Forward-looking statements are based
on the opinions and estimates of management at the date the
statements are made and are subject to a variety of risks and
uncertainties and other factors that could cause actual events or
results to differ materially from those projected in the
forward-looking statements. The Company is under no obligation, and
expressly disclaims any intention or obligation, to update or
revise any forward-looking statements, whether as a result of new
information, future events or otherwise, except as expressly
required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services
Provider accepts responsibility for the adequacy or accuracy of
this release.
View original
content:https://www.prnewswire.com/news-releases/nanalysis-scientific-corp-announces-upsize-to-private-placement-of-units-301811861.html
SOURCE Nanalysis Scientific Corp.